Business Wire

TX-MARY-KAY

8.3.2023 19:33:38 CET | Business Wire | Press release

Share
For Mary Kay, It’s Mission Critical: We’ve Accelerated Our Digital Innovation Efforts to Unleash the Full Potential of Women Entrepreneurs

Below is a statement by Deborah Gibbins, Chief Operating Officer, Mary Kay Inc., in celebration of International Women’s Day 2023.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230308005697/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Deborah Gibbins, Mary Kay’s Chief Operating Officer (Photo courtesy: Mary Kay Inc.)

37% of women worldwide do not have access to the internet. I know - I had to read that twice, too.1

37%! The number is staggering. It feels impossible. In our always-on, always-connected world, how can more than a third of all women in the world remain “unconnected”? This shocking reality - and its implications - fuel this year’s International Women’s Day theme: “DigitALL: Innovation and technology for gender equality.”

As Chief Operating Officer at Mary Kay, I know the role technology plays in all aspects of business – especially entrepreneurial business. To maximize the opportunity offered by technology, digital literacy skills are an absolute requirement for women entrepreneurs to fully participate in our global economy. They are also a necessity for civic and social engagement.

The foundations for the Fourth Industrial Revolution are digital and they are being laid right now. For all of us this revolution holds the tremendous opportunity to leverage technology and innovation to advance women entrepreneurship and equality. The time is now to ensure women reap the benefits of this digital transformation.

The digital economy won’t wait for anyone to catch up. Women’s exclusion from the digital world has shaved $1 trillion from the gross domestic product of low- and middle-income countries in the last decade.2 Once again, change is not happening fast enough for women.

We can fix this. We must fix this.

To reach their full potential, women business owners around the world must not only have access to the digital tools we take for granted, but they must have the right skills and training to use them effectively.

That’s why bridging the digital gender gap is so personal to us at Mary Kay, a company founded by a woman for women.

Our founder, Mary Kay Ash, had a vision to offer women unmatched entrepreneurial opportunities for advancement and personal success. That means something different today than it did in the ‘60s, but that same spirit remains. As an entrepreneurship development company, our focus is lifting women entrepreneurs up and addressing the barriers they face in establishing or growing their business. Digitalization is one of them.

At Mary Kay, we are determined to put women entrepreneurs at the center of the digital transformation.

We’ve accelerated our digital innovation efforts – this includes revolutionizing Mary Kay’s Independent Beauty Consultants’ (IBCs) ability to unleash their full potential through digital upskilling, the development and roll-out of innovative digital tools, from award-winning apps featuring augmented reality (AR), to connecting IBCs with their customers in more effective and seamless ways. We’re improving not only the experience for the independent sales force, but for their customers around the world.

Here are some of the latest examples of our commitment to empower Mary Kay’s independent sales force to harness the power of digital:

  • In Europe, our award-winning “Link & Learn” is an integrated education platform comprising a robust learning curriculum IBCs can access anytime, anywhere. This self-paced, interactive learning system helps consultants put their dreams into action by providing a competency-based curriculum with relevant, expert-driven content while connecting them with a community of like-minded consultants. It includes content focused on the key areas of competency that are essential for success at each step of the career path. With this content, consultants strategically focus on key topics and acquire skills such as Selling Skills, Business Skills, Product Knowledge and Understanding the Mary Kay Way. Mary Kay has received numerous awards for this educational platform, including a coveted gold ranking in the Education category in the “2019 Spring Omni Awards.” In 2021 Mary Kay Poland received the “Innovative Company” award for the program from the Home & Market magazine, and in 2018 it was awarded a “Technology Excellence Award” from the Brandon Hall Group.
  • The InTouch® platform is a one-stop shop mobile platform which provides millions of IBCs around the world 24-hour access to information, and services to effectively manage their Mary Kay business. It includes many features to enhance their knowledge of the beauty industry through product education, basic business skills through marketing and sales tools, and a professional network. With this app, IBCs can access product ingredient information and material to share with their customers or as a quick reference.
  • The Salesforce.com platform has also recently been rolled out to our Mary Kay markets via the Mary Kay InTouch site, enabling a more seamless use of digital technology in day-to-day operations, including placing orders. IBCs receive 24/7 support from their local Mary Kay teams and save time to focus on tasks that add more value to their business.
  • Mary Kay Mirror Me™ is our real-time makeover app using augmented reality to apply makeup trends and color products for real life application. After finding their perfect look, customers can add products to their shopping bag and connect with an IBC. Mirror Me™ is available in the North America, Europe and Latin America regions.
  • Mary Kay® Skin Analyzer is a tool that brings skin care and technology together at one’s fingertips. It helps customers understand the unique characteristics of their skin and create a customized skin care routine and is available in the North America, Asia-Pacific and Latin America regions.
  • And finally, the newly launched Mary Kay Interactive Catalog brings Mary Kay catalogs to life with easy product ordering, GIFs, videos, shareable wish lists, instant augmented reality makeovers and more. The catalog is available in the North America, Europe and Latin America regions.

We also believe in digital collaborations to help women entrepreneurs harness the power of digital throughout the world. To this end, we have joined forces with:

And we’re just getting started. The digital revolution is underway. Let’s not miss out on this golden opportunity to enable women and girls to champion entrepreneurship in the digital age!

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in more than 35 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn or follow us on Twitter.

1 ITU (2022). Facts and Figures 2022 - The gender digital divide (itu.int)

2 UN Women. Progress on the Sustainable Development Goals. The Gender Snapshot 2022.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005697/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye